COMMUNIQUÉS West-GlobeNewswire

LifeMD Reports Fourth Quarter 2024 Results
10/03/2025
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60% Adjusted EBITDA increased 78% to $9.0 million Telehealth adjusted EBITDA increased 396% to $5.9 million Full-year cash [...]
Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs
10/03/2025
All resolutions approved by bondholders Closing of Royalty Financing and receipt of first €130 million instalment expected shortly Upon closing of the Royalty Financing, GENFIT will implement the Repurchase of the 2025 [...]
Royalty Financing avec HCRx : GENFIT annonce l’approbation de la modification des modalités de ses OCEANEs 2025
10/03/2025
Approbation de toutes les résolutions par les porteurs d’OCEANEs 2025 Closing du Royalty Financing et réception de la première tranche de 130 millions d’euros attendus prochainement À la suite du closing du Royalty [...]
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
10/03/2025
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 Mont-Saint-Guibert, Belgium – Monday, March 10, 2025, 10:05pm CET / 5:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025
10/03/2025
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Exercice 2024 le 13 Mars 2025 Mont-Saint-Guibert, Belgique – 10 mars 2025, 22h05 CET / 17h05 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« [...]
Viemed Healthcare Announces Record 2024 Financial Results
10/03/2025
LAFAYETTE, La., March 10, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]
Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/03/2025
SAN DIEGO, March 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on March 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock [...]
Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update
10/03/2025
– Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures – – UDENYCA ® net revenue increased 62% year-over-year – – LOQTORZI ® net revenue increased 29% quarter-over-quarter – – [...]
OnKure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
10/03/2025
— PIKture-01 trial update including additional PK data, mature single agent and initial combination data expected in the second half of 2025; reported encouraging preliminary data in December 2024 — Expansion of PI3K a [...]
The Ensign Group to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference on March 18, 2025
10/03/2025
SAN JUAN CAPISTRANO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
10/03/2025
A new batch of neflamapimod capsules led to increased plasma drug concentrations and demonstrated improvement (p<0.001 vs. old capsules; p=0.003 vs. placebo) on the primary outcome measure, change from baseline in [...]
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
10/03/2025
Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy MyPEAK-1 Cohort 1 Data Accepted for Late-Breaker Presentation at the [...]
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock
10/03/2025
RADNOR, Pa., March 10, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD [...]
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
10/03/2025
NEWTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers [...]
There Is Hope for American Medicine, Writes President of the Association of American Physicians and Surgeons (AAPS)
10/03/2025
TUSCON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Hope, a very small word with a very large impact, is powerful. Without hope, all is futility, writes Erika L. LeBaron, D.O., M.S.N ., in the spring issue of the Journal [...]
Defenses against Sham Peer Review Discussed in the Journal of American Physicians and Surgeons
10/03/2025
TUSCON, Ariz. , March 10, 2025 (GLOBE NEWSWIRE) -- False accusations of being a “disruptive physician” can ruin a physician’s career as well as cause moral injury that damages the very core of a physician’s identity, [...]
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
10/03/2025
Presentations highlight relationship between semaglutide and blood markers of gene modification age predictors, gut bacteria, heart and metabolic effects, and fat in the liver LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE [...]
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
10/03/2025
Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 IMC-M113V was well tolerated, with no dose-limiting toxicities Signals of dose-dependent [...]
Long-term Brain Effects from COVID Vaccine Discussed in the Journal of American Physicians and Surgeons
10/03/2025
TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Rushed into production, the mRNA COVID vaccine was administered to 100 million people too soon to see any possible long-term neurologic effects, particularly in babies [...]

Pages